PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-23.19%
Cash & equivalents declining -23.19% while MRVL's grows 32.71%. Howard Marks would question why our liquidity is shrinking while competitor builds cash.
20.62%
Higher Short-Term Investments Growth compared to MRVL's zero value, indicating better performance.
0.07%
Below half of MRVL's 32.71%. Michael Burry might suspect a liquidity shortfall if there's no alternative capital plan.
4.21%
Receivables growth 50-75% of MRVL's 8.41%. Bruce Berkowitz would note relatively tighter receivables. Check if sales remain robust.
13.41%
Inventory growth 1.25-1.5x MRVL's 9.29%. Martin Whitman worries about slower turnover or potential markdown risk.
-11.50%
Similar to MRVL's -12.86%. Walter Schloss would confirm standard short-term asset patterns.
3.27%
Below half of MRVL's 12.16%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
11.22%
≥ 1.5x MRVL's 0.17%. David Dodd sees more aggressive capex. Confirm it's not overspending.
No Data
No Data available this quarter, please select a different quarter.
2.14%
Less than half of MRVL's -4.18%. David Dodd sees relatively fewer intangible expansions. Possibly more tangible-driven.
0.07%
Less than half of MRVL's -1.27%. David Dodd sees fewer intangible expansions vs. competitor. Possibly safer balance sheet.
531.03%
≥ 1.5x MRVL's 3.15%. David Dodd sees an aggressive push into LT investments. Confirm risk management.
10.49%
Less than half of MRVL's -6.42%. David Dodd sees fewer tax deferrals or losses, indicating stronger profitability vs. competitor.
10.56%
Similar yoy growth to MRVL's 11.39%. Walter Schloss sees parallel approach in non-core expansions.
8.65%
Below half of MRVL's -0.99%. Michael Burry might suspect stagnation or lack of resources for expansions.
No Data
No Data available this quarter, please select a different quarter.
5.88%
≥ 1.5x MRVL's 0.56%. David Dodd notes a larger balance sheet expansion. Confirm it's not overleveraged.
-3.05%
Less than half of MRVL's -11.35%. David Dodd sees a more disciplined AP approach or lower volume.
-40.20%
Less than half of MRVL's 781.92%. David Dodd sees much smaller short-term leverage burden vs. competitor.
-67.47%
1.1-1.25x MRVL's -56.20%. Bill Ackman wonders if the firm is deferring more or earning more than competitor.
No Data
No Data available this quarter, please select a different quarter.
17.64%
50-75% of MRVL's 33.78%. Bruce Berkowitz notes a more controlled liability line.
-6.65%
Less than half of MRVL's 38.72%. David Dodd sees a more disciplined short-term liability approach.
13.44%
Less than half of MRVL's -11.60%. David Dodd sees more deleveraging vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-5.48%
50-75% of MRVL's -10.33%. Bruce Berkowitz notes relatively lower DTL growth.
-5.46%
Less than half of MRVL's 510.47%. David Dodd notes more conservative expansions in non-current obligations.
10.97%
Less than half of MRVL's -10.83%. David Dodd sees a more conservative approach to non-current liabilities.
No Data
No Data available this quarter, please select a different quarter.
7.31%
Above 1.5x MRVL's 0.89%. Michael Burry sees a potential leverage warning sign.
No Data
No Data available this quarter, please select a different quarter.
1.16%
Below half MRVL's -3.67%. Michael Burry suspects major net losses or high dividends vs. competitor.
2.38%
Higher AOCI Growth compared to MRVL's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
4.57%
≥ 1.5x MRVL's 0.42%. David Dodd sees stronger capital base growth than competitor.
5.88%
≥ 1.5x MRVL's 0.56%. David Dodd sees faster overall balance sheet growth than competitor.
20.62%
≥ 1.5x MRVL's 3.15%. David Dodd sees far stronger investment expansions than competitor.
10.79%
Above 1.5x MRVL's 1.35%. Michael Burry sees a major jump. Investigate leverage rationale.
37.72%
Less than half of MRVL's -2.22%. David Dodd sees better deleveraging or stronger cash buildup than competitor.